$610.86
Currently 34 wall-street analysts regularly analyze the financials of Regeneron Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 34 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals, Inc. (REGN) have a share price target of $850.21. This median of share price forecast represents a 39.18% upside from the latest price of $610.86 as on 29.04.25.
As per the chart shown above, analysts believe that the Regeneron Pharmaceuticals, Inc. (REGN) share price will touch around $850.21 in next 12-months.
Below is a chart showing the percentage difference between Regeneron Pharmaceuticals, Inc.'s share price and its median forecast price. As on 29.04.25, the difference is -27.43%
Based on 34 analysts tracking and researching Regeneron Pharmaceuticals, Inc. (REGN) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 18 | 17 | 17 |
Outperform | 8 | 9 | 9 |
Hold | 5 | 7 | 7 |
Underperform | 0 | 0 | 0 |
Sell | 1 | 1 | 1 |